Literature DB >> 27272576

The Potential for Postrandomization Confounding in Randomized Clinical Trials.

JoAnn E Manson1, Chrisandra L Shufelt2, James M Robins3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27272576     DOI： 10.1001/jama.2016.3676

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

1.  Association of Statin Use with Increased Risk of Musculoskeletal Conditions: A Retrospective Cohort Study.

Authors:  Una E Makris; Carlos A Alvarez; Eric M Mortensen; Ishak A Mansi
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  The Impact of Treatment Preferences in Second-Line Chemotherapy on the Prognosis of HER2-Negative Metastatic Breast Cancer.

Authors:  Hirofumi Mukai; Yasuhiro Hagiwara; Kentaro Imi; Hirotsugu Isaka; Kenichi Watanabe; Yutaka Matsuyama
Journal:  Oncology       Date:  2017-08-24       Impact factor: 2.935

Review 3.  Design and conduct of confirmatory chronic pain clinical trials.

Authors:  Nathaniel Katz
Journal:  Pain Rep       Date:  2020-12-18

Review 4.  Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.

Authors:  Jonathan D Newman; Arthur Z Schwartzbard; Howard S Weintraub; Ira J Goldberg; Jeffrey S Berger
Journal:  J Am Coll Cardiol       Date:  2017-08-15       Impact factor: 24.094

Review 5.  The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review.

Authors:  Jonathan D Newman; Anish K Vani; Jose O Aleman; Howard S Weintraub; Jeffrey S Berger; Arthur Z Schwartzbard
Journal:  J Am Coll Cardiol       Date:  2018-10-09       Impact factor: 24.094

6.  Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.

Authors:  JoAnn E Manson; Aaron K Aragaki; Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Rowan T Chlebowski; Barbara V Howard; Cynthia A Thomson; Karen L Margolis; Cora E Lewis; Marcia L Stefanick; Rebecca D Jackson; Karen C Johnson; Lisa W Martin; Sally A Shumaker; Mark A Espeland; Jean Wactawski-Wende
Journal:  JAMA       Date:  2017-09-12       Impact factor: 56.272

7.  History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial.

Authors:  Cora E Lewis; John P Bantle; Alain G Bertoni; George Blackburn; Frederick L Brancati; George A Bray; Lawrence J Cheskin; Jeffrey M Curtis; Caitlin Egan; Mary Evans; John P Foreyt; Siran Ghazarian; Bethany Barone Gibbs; Stephen P Glasser; Edward W Gregg; Helen P Hazuda; Louise Hesson; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; Dalane Kitzman; William C Knowler; Edward Lipkin; Sara Michaels; Maria G Montez; David M Nathan; Ebenezer Nyenwe; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David M Reboussin; Donna H Ryan; Thomas A Wadden; Lynne E Wagenknecht; Holly Wyatt; Rena R Wing; Susan Z Yanovski
Journal:  Obesity (Silver Spring)       Date:  2020-01-03       Impact factor: 5.002

8.  The Quality of Randomized Controlled Trials in High-impact Rheumatology Journals, 1998-2018.

Authors:  Michael S Putman; Ashley Harrison Ragle; Eric M Ruderman
Journal:  J Rheumatol       Date:  2020-04-01       Impact factor: 4.666

9.  Postrandomization Confounding Challenges the Applicability of Randomized Clinical Trials in Comparative Effectiveness Research.

Authors:  Ya-Guang Peng; Xiao-Lu Nie; Jing-Jing Feng; Xiao-Xia Peng
Journal:  Chin Med J (Engl)       Date:  2017-04-20       Impact factor: 2.628

10.  Mechanism evaluation of a lifestyle intervention for patients with musculoskeletal pain who are overweight or obese: protocol for a causal mediation analysis.

Authors:  Hopin Lee; John Wiggers; Steven J Kamper; Amanda Williams; Kate M O'Brien; Rebecca K Hodder; Luke Wolfenden; Sze Lin Yoong; Elizabeth Campbell; Robin Haskins; Emma K Robson; James H McAuley; Christopher M Williams
Journal:  BMJ Open       Date:  2017-07-03       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.